Healthcare -
Biotechnology - NASDAQ - US
$ 5.435
-1.54 %
$ 372 M
Market Cap
-0.95
P/E
Price Target
Average
292.52%
Revenue Forecast
Estimate
946.29%
EBIT
Estimate
68.70%
Net Income
Estimate
37.67%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Phathom Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for PHAT of $21.3 , with forecasts ranging from
a
low of
$12 to a high of $28 .
PHAT Lowest Price Target
Wall Street Target
12 USD
120.79%
PHAT Average Price Target
Wall Street Target
21.3 USD
292.52%
PHAT Highest Price Target
Wall Street Target
28 USD
415.18%
REVENUE FORECAST
Revenue Forecast Chart PHAT
EBIT FORECAST
EBIT Forecast Chart PHAT
NET INCOME FORECAST
Net Income Chart PHAT